Literature DB >> 21791949

Gonadal development and tumor formation at the crossroads of male and female sex determination.

M Cools1, K P Wolffenbuttel, S L S Drop, J W Oosterhuis, L H J Looijenga.   

Abstract

Malignant germ cell tumor (GCT) formation is a well-known complication in the management of patients with a disorder of sex development (DSD). DSDs are defined as congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. DSD patients in whom the karyotype - at least at the gonadal level - contains (a part of) the Y chromosome are at increased risk for neoplastic transformation of germ cells, leading to the development of the so-called 'type II germ cell tumors'. However, tumor risk in the various forms of DSD varies considerably between the different diagnostic groups. This contribution integrates our actual knowledge on the pathophysiology of tumor development in DSDs, recent findings on gonadal (mal)development in DSD patients, and possible correlations between the patient's phenotype and his/her risk for germ cell tumor development.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791949     DOI: 10.1159/000329477

Source DB:  PubMed          Journal:  Sex Dev        ISSN: 1661-5425            Impact factor:   1.824


  17 in total

1.  A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development.

Authors:  Stefan White; Jacqueline Hewitt; Erin Turbitt; Yvonne van der Zwan; Remko Hersmus; Stenvert Drop; Peter Koopman; Vincent Harley; Martine Cools; Leendert Looijenga; Andrew Sinclair
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Authors:  Anthony N Karnezis; Kathleen R Cho; C Blake Gilks; Celeste Leigh Pearce; David G Huntsman
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

Review 3.  Disorders of sex development: new genes, new concepts.

Authors:  Makoto Ono; Vincent R Harley
Journal:  Nat Rev Endocrinol       Date:  2012-12-18       Impact factor: 43.330

4.  The ethics of offering fertility preservation to pediatric patients: A case-based discussion of barriers for clinicians to consider.

Authors:  Erin E Rowell; Timothy B Lautz; Krista Lai; Erica M Weidler; Emilie K Johnson; Courtney Finlayson; Kathleen van Leeuwen
Journal:  Semin Pediatr Surg       Date:  2021-09-04       Impact factor: 1.900

Review 5.  Developmental Programming of Ovarian Functions and Dysfunctions.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

6.  Ex vivo culture of human fetal gonads: manipulation of meiosis signalling by retinoic acid treatment disrupts testis development.

Authors:  A Jørgensen; J E Nielsen; S Perlman; L Lundvall; R T Mitchell; A Juul; E Rajpert-De Meyts
Journal:  Hum Reprod       Date:  2015-08-06       Impact factor: 6.918

7.  Clinical and gonadal features and early surgical management of 45,X/46,XY and 45,X/47,XYY chromosomal mosaicism presenting with genital anomalies.

Authors:  M K Farrugia; N J Sebire; J C Achermann; A Eisawi; P G Duffy; I Mushtaq
Journal:  J Pediatr Urol       Date:  2012-01-26       Impact factor: 1.830

Review 8.  Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS).

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Mirko Bertozzi; Laura Penta; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-04-09       Impact factor: 3.390

9.  Germ Cell Tumors in Dysgenetic Gonads.

Authors:  Mauri José Piazza; Almir Antonio Urbanetz
Journal:  Clinics (Sao Paulo)       Date:  2019-11-11       Impact factor: 2.365

10.  A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment.

Authors:  Daniel Nettersheim; Sina Jostes; Martin Fabry; Friedemann Honecker; Valerie Schumacher; Jutta Kirfel; Glen Kristiansen; Hubert Schorle
Journal:  Oncotarget       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.